PDCD1 and small cell lung carcinoma: In ES-SCLC, studies have shown that PD-1/PD-L1 inhibitors combined with chemotherapy are safer and more effective than chemotherapy alone, whereas PD-1/PD-L1 inhibitors combined with CTLA-4 inhibitors did not improve the efficacy (55).